FDA Inspection
The Procter & Gamble Manufacturing CompanyThe Procter & Gamble Manufacturing Company – FDA Inspection, Apr 15, 2011
Record Details
This FDA Inspection record concerns The Procter & Gamble Manufacturing Company, with an inspection on April 15, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 15, 2011
- Product Type
- Drugs
View Company Profile
ID · aa573614-4f3c-4cd7-81e6-50a9785ea6ed
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 720198
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of The Procter & Gamble Manufacturing Company
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 3, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 26, 2020 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| August 15, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 11, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 9, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for The Procter & Gamble Manufacturing Company
- FDA Inspection 1173057 - 2022-06-03
- FDA Inspection 1120284 - 2020-02-26
- FDA Inspection 987633 - 2016-08-15
- FDA Inspection 781358 - 2012-05-11
- FDA Inspection 633906 - 2009-12-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.